
On November 8th, Lelaiwa organized a training session to review the medical insurance policies within the organization. With the National Medical Insurance Administration proposing to “unify the payment scope for assisted reproduction services,” and various local regulations being finalized one after another, we have compiled the latest guidelines in detail. The goal is to ensure that every advisor’s responses are based on the most up-to-date official information, rather than relying solely on memory or personal experience.
The "time difference" in policies is the main risk factor for services. While the national guidelines are clear, local regulations, quotas, and filing procedures vary from place to place, and often require dynamic adjustments. If consultants use outdated versions of these guidelines, it can lead to misleading expectations among clients. Reviewing regularly is necessary to eliminate this time difference.
Compare with the catalogues released in various regions, and verify the coverage of the five most common procedures: egg retrieval, embryo culture, transplantation, sperm selection, and intracytoplasmic sperm injection.
We have identified the latest procedures and common issues related to online registration on the national medical insurance service platform. We ensure that the instructions are accurate and helpful.
It is important to understand the difference between “unified scope” and “unified ratio”. This helps prevent customers from misunderstanding it as “national unified reimbursement”.
Include compliant descriptions of high-frequency issues in the standard response database, thereby reducing personalized biases.
In terms of policy-related services, the use of vague expressions like “probably” or “should” should be strictly avoided. We would rather include a sentence like “Please refer to official sources” than provide any misleading information that seems certain. Conducting review sessions is precisely about institutionalizing this cautious approach.